Campbell & CO Investment Adviser LLC Acquires New Position in Waters Corporation $WAT

Campbell & CO Investment Adviser LLC purchased a new stake in Waters Corporation (NYSE:WAT) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 9,963 shares of the medical instruments supplier’s stock, valued at approximately $3,477,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of WAT. Swedbank AB grew its holdings in Waters by 25.8% during the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock worth $14,145,000 after acquiring an additional 8,305 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Waters by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock valued at $195,599,000 after purchasing an additional 28,018 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Waters by 12.6% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock worth $2,800,000 after purchasing an additional 896 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new position in shares of Waters during the first quarter worth $1,244,000. Finally, Mn Services Vermogensbeheer B.V. grew its stake in shares of Waters by 7.0% during the second quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock worth $8,005,000 after purchasing an additional 1,500 shares in the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on WAT shares. Rothschild & Co Redburn started coverage on Waters in a report on Wednesday, October 8th. They set a “buy” rating and a $390.00 price target for the company. UBS Group reissued a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Robert W. Baird reduced their price objective on shares of Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a research report on Wednesday, July 16th. Wells Fargo & Company increased their target price on shares of Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a research report on Wednesday. Finally, Redburn Partners set a $390.00 price target on shares of Waters in a research note on Wednesday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $381.57.

Waters Stock Up 0.2%

WAT stock opened at $371.97 on Friday. The company has a market cap of $22.15 billion, a price-to-earnings ratio of 33.54, a P/E/G ratio of 3.19 and a beta of 1.11. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The business has a 50 day moving average price of $323.54 and a two-hundred day moving average price of $326.08. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55.

Waters (NYSE:WAT) last released its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $608.55 million during the quarter. Analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.